Duplex Ultrasound Factors Predicting Persistent Type II Endoleak and Increases in Abdominal Aortic Aneurysm Sac Diameter After Endovascular Aneurysm Repair  by Beeman, Brian R. et al.
JOURNAL OF VASCULAR SURGERY
Volume 51, Number 4 Abstracts 106998.8%]) and OSR (100%, P  .05). The 5-year all-cause survival was
significantly reduced in the EVAR group (50.4%, 95% CI, 34%-66%.) vs
OSR (80.4%, [95% CI, 66.9%-89.5%; P  .0279; h, 0.34 [95% CI, 0.12-
0.94]). However, none of the deaths in the EVAR group were aneurysm-
related. The 30-day morbidity (P  .0001), length of hospital stay (P 
.0001), 5-year quality-adjusted time spent without symptoms of disease and
toxicity of treatment (P  .01), and cost per QALY (P  .01) were all
significantly reduced with EVAR compared with OSR.
Conclusions: Endografts can be effectively used to treat difficult
pararenal AAAs, with enhanced long-term aneurysm-related survival,
cost-effectiveness, and quality of life, and with significantly reduced
perioperative morbidity, mortality, and waiting time from diagnosis to
treatment.
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Objective: Although the significance of type II endoleaks (T2ELs) on
the long-term outcome of endovascular repair (EVAR) of abdominal aortic
aneurysms (AAAs) is debatable, duplex ultrasound (DUS) parameters have
been suggested to be predictive of their closure or persistence. The purpose
of this study was to determine which, if any, of these variables was associated
with persistent T2ELs or increased AAA sac diameter.
Methods: Between 1998 and 2009, 278 patients underwent EVAR
and postoperative DUS surveillance during long-term follow-up (range,
1-11 years) in our accredited noninvasive vascular laboratory by one of three
experienced technologists. DUS was used to measure intrasac flow velocity
(IFV), spectral Doppler waveform (SDW) patterns, post-EVAR sac diame-
ter, and number of T2ELs per patient.
Results: T2ELs developed in 38 patients (14%) after EVAR: 14 had
T2ELs that resolved and sac diameter decreased or remained the same
(average IFV, 42 cm/s). SDW patterns were monophasic in 5, biphasic in 7,
and bidirectional in 2. Multiple T2ELs were not present (0%) in any patient.
Twelve patients had T2ELs that persisted but sac diameter decreased or
remained the same (average IFV, 47 cm/s). SDW patterns were
monophasic in 1, biphasic in 5, bidirectional in 5, and undetermined in 1.
Multiple T2ELs were found in two patients (17%). T2ELs persisted in 12
patients and were associated with increased sac diameter (average IFV, 43
cm/s). SDW patterns were monophasic in 1, biphasic in 2, and bidirec-
tional in 9. Multiple T2Els were identified in nine patients (75%). None
of the 38 patients with T2ELs treated with selective surgical or endovas-
cular intervention for enlarging sac diameters (9 of 12) experienced a
ruptured aneurysm.
Conclusions: Contrary to previous reports, parameters such as
intrasac flow velocity and spectral Doppler waveform patterns of T2ELs
did not correlate with increased post-EVAR sac diameter. The presence
of multiple T2ELs may be the strongest factor predictive of increased sac
diameter.
Table. Patency data for percutaneous transluminal angiop
Variable 6 mon 12 mon
Primary patency
Female 75.5  3.3 66.9  3
Male 60.5  3.2 48.1  3
P .001 .0001
Primary-assisted patency
Female 80.0  3.0 75.2  3
Male 66.7  3.1 57.5  3
P .003 .0001
Secondary patency
Female 81.8  2.9 79.1  3
Male 69.2  3.0 62.6  3
P .004 .001
Limb salvage
Female 89.7  2.4 88.2  2
Male 80.7  2.6 74.0  3
P .005 .001DuplexUltrasoundGraft LimbVelocity Asymmetry Predicts Endoleak
After Endovascular Aneurysm Repair
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Objective: Ultrasound (US) surveillance after endovascular aneurysm
repair (EVAR) may be suboptimal compared with computed tomography
(CT) imaging due to its limited ability to assess the complete stent graft and
aneurysm sac. We evaluated our US surveillance program to identify surro-
gate markers independent of CT that may predict endoleak after EVAR.
Methods: Patient records were reviewed for all EVAR procedures
performed between October 1999 and June 2009 from our prospectively
maintained database. Postoperative surveillance protocol involved CT and
US imaging 30 days and at 6- and 12-month intervals. US imaging
parameters included maximum aneurysm diameter, presence of endoleak,
and graft limb flow velocities that were considered asymmetric if they
differed by 5 cm/s.
Results: During this 10-year period, 927 patients underwent 1062
EVAR procedures and 3120 postoperative imaging encounters, of which
1589 (50.9%) had US imaging. US identified an endoleak in 186
encounters (11.7%): 17 type I, 166 type II, and 3 type III. Asymmetric
graft limb velocity (AGLV) was identified in 494 US encounters (30.9%),
of which 150 US images (9.4%) had endoleak, and 36 endoleaks (2.3%)
were identified in those encounters with symmetric velocities. Logistic
regression showed a significant association between AGLV and any type
of endoleak (odds ratio [OR], 12.9; 95% confidence interval [CI],
8.8-18.9; P  .0001). Further analysis showed a significant association
between AGLV and type I (OR, 7.4; 95% CI, 2.6-21.3; P  .0002) and
type II endoleaks (OR, 13.5; 95% CI, 9.0-20.3; P  .0001). CT
comparison of 561 encounters from the same cohort identified a signif-
icant association between AGLV and any type of endoleak identified on
CT (OR, 1.5; 95% CI, 1.05-2.3; P .026), or CT type II endoleak (OR,
1.6; 95% CI, 1.1-2.4; P  .022).
Conclusions: Asymmetric graft limb velocities during US surveillance
may act as a surrogate marker to predict endoleaks that are not directly
visualized by US. Using graft limb velocities may simplify the surveillance
protocol after EVAR and may reduce the need for repeated CT imaging.
Gender Differences in the Outcome of Endovascular Interventions for
Peripheral Arterial Disease: Is There a Difference Between Men and
Women Treated with Angioplasty or Angioplasty and Stenting?
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Objective: The expression and presentation of peripheral arterial dis-
ease (PAD) differs between men and women; however, the outcomes based
on endovascular technique and gender are unknown. This study assessed the
outcomes of women compared with men treated with lower extremity
percutaneous transluminal angioplasty (PTA) alone or PTA and stenting
(PTAStent) to determine the optimal therapy.
Methods: We performed a prospective study evaluating the outcomes
of PTA and PTAStent for PAD. Indications for intervention included
alone in men vs women
18 mon 24 mon 30 mon
58.3  4.1 51.6  4.5 50.0  4.6
41.4  3.8 36.1  4.0 36.1  4.0
.0001 .0001 .0001
68.4  3.9 62.8  4.3 61.0  4.6
51.2  3.8 50.0  3.9 48.6  4.1
.0001 .001 .001
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